Marc Turner

2.4k total citations
19 papers, 893 citations indexed

About

Marc Turner is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, Marc Turner has authored 19 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Physiology and 4 papers in Immunology. Recurrent topics in Marc Turner's work include Pluripotent Stem Cells Research (4 papers), Biomedical Ethics and Regulation (3 papers) and CRISPR and Genetic Engineering (3 papers). Marc Turner is often cited by papers focused on Pluripotent Stem Cells Research (4 papers), Biomedical Ethics and Regulation (3 papers) and CRISPR and Genetic Engineering (3 papers). Marc Turner collaborates with scholars based in United Kingdom, United States and Australia. Marc Turner's co-authors include Dorothy H. Crawford, Tanzina Haque, P L Amlot, Gwen Wilkie, David Burns, Karen A. McAulay, Déirdre Kelly, Alastair MacGilchrist, Craig Higgins and Anthony J. Swerdlow and has published in prestigious journals such as Blood, Nature Biotechnology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Marc Turner

18 papers receiving 876 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marc Turner United Kingdom	11	465	262	238	193	142	19	893
Chiara Ratti Italy	16	183 0.4×	242 0.9×	209 0.9×	244 1.3×	26 0.2×	41	1.2k
Elias Bachmann Switzerland	17	614 1.3×	95 0.4×	257 1.1×	100 0.5×	520 3.7×	59	1.1k
Po Wing Yuen Hong Kong	21	587 1.3×	469 1.8×	82 0.3×	83 0.4×	93 0.7×	33	1.5k
Hitoshi Minamiguchi Japan	14	156 0.3×	318 1.2×	82 0.3×	152 0.8×	19 0.1×	38	910
Jaakko Pulkkinen Finland	15	351 0.8×	267 1.0×	75 0.3×	32 0.2×	58 0.4×	33	1.0k
Martin Ryser Germany	15	122 0.3×	297 1.1×	66 0.3×	131 0.7×	17 0.1×	28	594
Rita Fazzi Italy	17	263 0.6×	261 1.0×	61 0.3×	91 0.5×	90 0.6×	47	881
Frédéric Lambert Belgium	11	196 0.4×	197 0.8×	75 0.3×	54 0.3×	80 0.6×	23	772
Yasushi Uemura Japan	21	586 1.3×	531 2.0×	34 0.1×	690 3.6×	26 0.2×	47	1.3k
Francis Young‐In Lee United States	17	156 0.3×	225 0.9×	113 0.5×	57 0.3×	33 0.2×	28	891

Countries citing papers authored by Marc Turner

Since Specialization

Citations

This map shows the geographic impact of Marc Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Turner more than expected).

Fields of papers citing papers by Marc Turner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Turner. The network helps show where Marc Turner may publish in the future.

Co-authorship network of co-authors of Marc Turner

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Turner. A scholar is included among the top collaborators of Marc Turner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Turner. Marc Turner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Candela, Maria Elena, Melisande Addison, Rhona Aird, et al.. (2025). Cryopreserved human alternatively activated macrophages promote resolution of acetaminophen-induced liver injury in mouse. npj Regenerative Medicine. 10(1). 5–5.

Galea, George, et al.. (2021). Essentials of Tissue and Cells Banking. 1 indexed citations

James, Richard, et al.. (2019). Cost and Performance Baseline for Fossil Energy Plants: Bituminous Coal and Natural Gas to Electricity. SSRN Electronic Journal. 34 indexed citations

Roberts, Daniel B. Hawcutt, & Marc Turner. (2017). PP-34 Adverse drug reactions in neonates: comparing retrospective spontaneous yellow card reports to prospectively collected reports. Archives of Disease in Childhood. 102(10). A28.1–A28. 1 indexed citations

Roberts, Daniel B. Hawcutt, & Marc Turner. (2017). O-24 Adrin 1 methodology study: adverse drug reactions in neonates: what are the best ways to evaluate suspected adverse drug reactions in neonates?. Archives of Disease in Childhood. 102(10). A11.2–A11. 2 indexed citations

Barry, Jacqueline, Johan Hyllner, Glyn Stacey, Craig J. Taylor, & Marc Turner. (2015). Setting Up a Haplobank: Issues and Solutions. Current Stem Cell Reports. 1(2). 110–117. 32 indexed citations

Andrews, Peter W., Joy Cavagnaro, Robert Deans, et al.. (2014). Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells. Nature Biotechnology. 32(8). 724–726. 44 indexed citations

Brittan, Mairi, Andrew Conway Morris, Daniel F. McAuley, et al.. (2013). A Randomized Controlled Trial of Peripheral Blood Mononuclear Cell Depletion in Experimental Human Lung Inflammation. American Journal of Respiratory and Critical Care Medicine. 188(4). 449–455. 13 indexed citations

Turner, Marc, Stephen Leslie, Nicholas G. Martin, et al.. (2013). Toward the Development of a Global Induced Pluripotent Stem Cell Library. Cell stem cell. 13(4). 382–384. 173 indexed citations

10.

Mountford, Joanne C. & Marc Turner. (2011). In vitro production of red blood cells. Transfusion and Apheresis Science. 45(1). 85–89. 13 indexed citations

11.

Turner, Marc, André Rieutord, Urvi A. Shah, et al.. (2011). The european study of neonatal exposure to excipients (ESNEE). 14 indexed citations

12.

Kerr, Shona M., David C. Liewald, Archie Campbell, et al.. (2010). Generation Scotland: Donor DNA Databank; A control DNA resource. BMC Medical Genetics. 11(1). 166–166. 2 indexed citations

13.

Mountford, Joanne C., Emmanuel Olivier, & Marc Turner. (2010). Prospects for the manufacture of red cells for transfusion. British Journal of Haematology. 149(1). 22–34. 27 indexed citations

14.

McAulay, Karen A., et al.. (2008). Cytolytic mechanisms and T‐cell receptor Vβ usage by ex vivo generated Epstein–Barr virus‐specific cytotoxic T lymphocytes. Immunology. 127(4). 577–586. 10 indexed citations

15.

MacDonald, Shirley L., I. Downing, Marc Turner, & David C. Kilpatrick. (2008). Is mannan-binding lectin (MBL) detectable on monocytes and monocyte-derived immature dendritic cells?. Biochemical Society Transactions. 36(6). 1497–1500. 3 indexed citations

16.

Haque, Tanzina, Gwen Wilkie, Craig Higgins, et al.. (2007). Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial. Blood. 110(4). 1123–1131. 452 indexed citations

17.

Wilkie, Gwen, Clare Taylor, David Burns, et al.. (2004). Establishment and Characterization of a Bank of Cytotoxic T Lymphocytes for Immunotherapy of Epstein-Barr Virus-Associated Diseases. Journal of Immunotherapy. 27(4). 309–316. 62 indexed citations

18.

Bessos, Hagop, et al.. (2003). The development of a quantitative ELISA for antibodies against human platelet antigen type 1a. Transfusion. 43(3). 350–356. 8 indexed citations

19.

Turner, Marc. (1998). The Risk of Transmission of nvCJD by Blood Transfusion and the Potential Benefits of Leucodepletion. Transfusion Science. 19(4). 331–332. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact